# Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

> **NCT00938717** · PHASE3 · COMPLETED · sponsor: **Ironwood Pharmaceuticals, Inc.** · enrollment: 805 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Constipation

## Interventions

- **DRUG:** Linaclotide or Matching Placebo

## Key facts

- **NCT ID:** NCT00938717
- **Lead sponsor:** Ironwood Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 805 (ACTUAL)
- **Last updated:** 2013-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938717, "Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00938717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*